Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report
Experimental and Therapeutic Medicine · 12.06.2026 · 32 (2) · 1-6
DOI: 10.3892/etm.2026.13209 ↗Kurz gefasst
Fallbericht in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 12.06.2026. Verfasst von Zhuo Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Liaohua Hospital, Liaoyang, Liaoning 111003, P.R. China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Liaohua Hospital, Liaoyang, Liaoning 111003, P.R. China.
- Department of Research, Liaohua Hospital, Liaoyang, Liaoning 111003, P.R. China.
Zitieren
APA
Wang, Z., Li, C., & Yue, L. (2026). Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report. Experimental and Therapeutic Medicine, 32(2), 1-6. https://doi.org/10.3892/etm.2026.13209
Vancouver
Wang Z, Li C, Yue L. Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report. Experimental and Therapeutic Medicine. 2026;32(2):1-6. doi:10.3892/etm.2026.13209
BibTeX
@article{Wang2026,
author = {Wang, Zhuo and Li, Chao and Yue, Lili},
title = {Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report},
journal = {Experimental and Therapeutic Medicine},
year = {2026},
volume = {32},
number = {2},
pages = {1--6},
doi = {10.3892/etm.2026.13209}
}
EUVIMED